Drug
Lifileucel Plus Pembrolizumab
Lifileucel Plus Pembrolizumab: highest development phase Phase 3, developed by Iovance Biotherapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Iovance Biotherapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lifileucel plus Pembrolizumab NCT05727904 | Phase 3 | Metastatic Melanoma |
Latest
No recent events.
Follow Lifileucel Plus Pembrolizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.